By Larry King TROON, Scotland, July 16 (Reuters) – Henrik Stenson will start the final round of the British Open leading the championship, and trying not to think about how it’s going to end. “Thoughts of outcome are never really helping you,” he said at a news conference after his third round at Royal Troon, where he gained a one shot advantage over American Phil Mickelson. There’s no question about it.” Stenson’s one-shot lead puts the 40-year-old Swede as close as he’s ever been to winning his first major.
A British man and five Germans have been charged with producing significant amounts of doping substances for athletes in an underground laboratory and distributing the drugs across Germany, prosecutors said on Tuesday. The Munich prosecutors say a 45-year-old British national has been running an underground laboratory in Waldkraiburg, near Munich, since 2009. Purchasing the required substances in countries outside Europe, he sold the drugs online to customers across Germany, earning about 120,000 euros ($130,000), the indictment said.
New research has added to tentative evidence that eating chocolate in modest quantities may be good for the heart, scientists said on Tuesday. The top fifth of chocolate-eaters were 12 percent less likely to develop heart disease and 23 percent less likely to suffer a stroke compared to the bottom fifth of consumers, the researchers found. The study, published in the British journal Heart, noted that most consumers of the confectionary ate milk chocolate, not dark chocolate which famously has a higher percentage of protective molecules called flavonoids.
Spider venom may contain a long-sought secret ingredient for an effective, long-term painkiller, researchers said Wednesday. In lab-dish tests, seven compounds obtained from venom blocked a protein crucial for transmitting the sensation of pain to the human brain. “The hunt for a medicine based on just one of these compounds, which would open up a new class of potent painkillers, is now a step closer,” said a statement issued with the study published by the British Journal of Pharmacology. If it could be targeted and controlled, this “off switch” may be the solution for millions of chronic pain sufferers.